Lurbinectedin is a chemotherapy drug used to treat cancer. It belongs to the class of drugs called alkylating agents and works by interfering with the DNA in cancer cells, preventing them from dividing and growing. This drug is primarily used to treat small-cell lung cancer and is typically given in combination with other chemotherapy drugs.

Brick42, together with partners has a fully developed, synthetic, and non-infringing process for the production of Lurbinectedin API yielding novel crystalline forms.

For more information please contact